Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro

Biophysical Journal

Volumn 101, Issue 8, 2011, Pages 1825-1834

  Venkatraman, Lakshmi ^a,b,c   Li, Huipeng ^a   Dewey Jr , C Forbes ^a,d   White, Jacob K ^a,e   Bhowmick, Sourav S ^a,c   Yu, Hanry ^a,b,f   Tucker Kellogg, Lisa ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d Massachusetts Institute of Technology Cambridge   (United States)

^e USA   (United States)

^f INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; UROKINASE;

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; CELL FREE SYSTEM; CHEMISTRY; ENZYME ACTIVATION; ENZYME STABILITY; METABOLISM; REPRODUCIBILITY;

CELL-FREE SYSTEM; COMPUTATIONAL BIOLOGY; ENZYME ACTIVATION; ENZYME STABILITY; FIBRINOLYSIN; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 80054713184     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2011.08.054     Document Type: Article

References (52)

1. P. Carmeliet, and D. Collen Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals Trends Cardiovasc. Med. 5 1995 117 122
2. W.D. Thompson, and C.M. Stirk E.B. Smith Plasmin, fibrin degradation and angiogenesis Nat. Med. 2 1996 493
3. M. Toriseva, and V.M. Kähäri Proteinases in cutaneous wound healing Cell. Mol. Life Sci. 66 2009 203 224
4. W. Zhang, and L. Tucker-Kellogg H. Yu Cell-delivery therapeutics for liver regeneration Adv. Drug Deliv. Rev. 62 2010 814 826
5. J.M. Rakic, and C. Maillard A. Noël Role of plasminogen activator-plasmin system in tumor angiogenesis Cell. Mol. Life Sci. 60 2003 463 473 (Pubitemid 36459526)
6. H.R. Lijnen Plasmin and matrix metalloproteinases in vascular remodeling Thromb. Haemost. 86 2001 324 333 (Pubitemid 32663963)
7. N. Ramos-DeSimone, and E. Hahn-Dantona J.P. Quigley Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion J. Biol. Chem. 274 1999 13066 13076
8. L.J. Hawinkels, and K. Zuidwijk C.F. Sier VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis Eur. J. Cancer 44 2008 1904 1913
9. K. Shanmukhappa, and U. Matte J.A. Bezerra Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair J. Biol. Chem. 284 2009 12917 12923
10. R.M. Lyons, and L.E. Gentry H.L. Moses Mechanism of activation of latent recombinant transforming growth factor β 1 by plasmin J. Cell Biol. 110 1990 1361 1367
11. W.Y. Li, and S.S. Chong T.L. Tuan Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen. 11 2003 239 247 (Pubitemid 36897519)
12. P.K. Anonick, B. Wolf, and S.L. Gonias Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by α2-antiplasmin, α2-macroglobulin, and antithrombin III in the presence of heparin Thromb. Res. 59 1990 449 462 (Pubitemid 20330326)
13. C. Chen, and J. Cui P. Shen Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision Biophys. J. 92 2007 4304 4315 (Pubitemid 46910545)
14. J. Cui, and C. Chen P. Shen Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch PLoS ONE 3 2008 e1469
15. E. Hahn-Dantona, and N. Ramos-DeSimone J.P. Quigley Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases Ann. N. Y. Acad. Sci. 878 1999 372 387 (Pubitemid 29353582)
16. M. Schenone, B.C. Furie, and B. Furie The blood coagulation cascade Curr. Opin. Hematol. 11 2004 272 277 (Pubitemid 39120956)
17. D. Angeli New analysis technique for multistability detection Syst. Biol. (Stevenage) 153 2006 61 69
18. U.S. Bhalla, and R. Iyengar Emergent properties of networks of biological signaling pathways Science 283 1999 381 387
19. C.Y. Huang, and J.E. Ferrell Jr. Ultrasensitivity in the mitogen-activated protein kinase cascade Proc. Natl. Acad. Sci. USA 93 1996 10078 10083 (Pubitemid 26314577)
20. N.I. Markevich, J.B. Hoek, and B.N. Kholodenko Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades J. Cell Biol. 164 2004 353 359 (Pubitemid 38174763)
21. C.P. Bagowski, and J.E. Ferrell Jr. Bistability in the JNK cascade Curr. Biol. 11 2001 1176 1182 (Pubitemid 32722570)
22. B.B. Aldridge, and J.M. Burke P.K. Sorger Physicochemical modelling of cell signalling pathways Nat. Cell Biol. 8 2006 1195 1203 (Pubitemid 44660581)
23. B. Novak, and J.J. Tyson A. Csikasz-Nagy Irreversible cell-cycle transitions are due to systems-level feedback Nat. Cell Biol. 9 2007 724 728 (Pubitemid 47019454)
24. T. Eissing, and S. Waldherr E. Bullinger Steady state and (bi-) stability evaluation of simple protease signalling networks Biosystems 90 2007 591 601 (Pubitemid 350026175)
25. S.Y. Kim, and J.E. Ferrell Jr. Substrate competition as a source of ultrasensitivity in the inactivation of Wee1 Cell 128 2007 1133 1145 (Pubitemid 46437260)
26. A.U. Lüthi, and S.J. Martin The CASBAH: a searchable database of caspase substrates Cell Death Differ. 14 2007 641 650 (Pubitemid 46444502)
27. H.R. Stennicke, and G.S. Salvesen Catalytic properties of the caspases Cell Death Differ. 6 1999 1054 1059
28. C. Chen, and J. Cui P. Shen Robustness analysis identifies the plausible model of the Bcl-2 apoptotic switch FEBS Lett. 581 2007 5143 5150 (Pubitemid 47576101)
29. D. Collen, and C. Zamarron M. Hoylaerts Activation of plasminogen by pro-urokinase. II. Kinetics J. Biol. Chem. 261 1986 1259 1266 (Pubitemid 16113088)
30. R. Pannell, and V. Gurewich Activation of plasminogen by single-chain urokinase or by two-chain urokinase - a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase) Blood 69 1987 22 26 (Pubitemid 17007070)
31. V. Ellis, M.F. Scully, and V.V. Kakkar Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study J. Biol. Chem. 262 1987 14998 15003 (Pubitemid 17160171)
32. M.A. Lucas, and D.L. Straight P.A. McKee The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity J. Biol. Chem. 258 1983 12171 12177 (Pubitemid 14230006)
33. H.R. Lijnen, and B. Van Hoef D. Collen The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitro Blood 73 1989 1864 1872 (Pubitemid 19145118)
34. N. Blüthgen, and S. Legewie B. Kholodenko Mechanisms generating ultrasensitivity, bistability, and oscillations in signal transduction S. Choi, Introduction to Systems Biology 2007 Humana Press Totowa, NJ 282 299
35. J.E. Ferrell Jr. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability Curr. Opin. Cell Biol. 14 2002 140 148 (Pubitemid 34219501)
36. G.D. Reinhart, and H.A. Lardy Rat liver phosphofructokinase: kinetic activity under near-physiological conditions Biochemistry 19 1980 1477 1484
37. K.C. Robbins, and L. Summaria Human plasminogen and plasmin J.N. Abelson, M.I. Simon, Methods in Enzymology 1970 Academic Press New York 184 199
38. H.R. Lijnen, and D. Collen Interaction of plasminogen activators and inhibitors with plasminogen and fibrin Semin. Thromb. Hemost. 8 1982 2 10 (Pubitemid 12148543)
39. D. Collen, and G. Tytgat P. Wallén Metabolism of plasminogen in healthy subjects: effect of tranexamic acid J. Clin. Invest. 51 1972 1310 1318
40. T. Soulat, and S. Loyau E. Anglés-Cano Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin - a study with individual plasmas presenting natural variations of Lp(a) Thromb. Haemost. 82 1999 121 127 (Pubitemid 29368784)
41. M. Shakespeare, and P. Wolf The demonstration of urokinase antigen in whole blood Thromb. Res. 14 1979 825 835 (Pubitemid 9209745)
42. K. Saito, and M. Nagashima A. Takada The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumors Thromb. Res. 58 1990 355 366 (Pubitemid 20146928)
43. H. Koelbl, and J.C. Kirchheimer B.R. Binder Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer Obstet. Gynecol. 72 1988 252 256
44. A. Wankiewicz, and I. Iwan-Zietek Z. Gwieździński Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis Med. Sci. Monit. 8 2002 CR189 CR192
45. E.Z. Bagci, and Y. Vodovotz I. Bahar Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores Biophys. J. 90 2006 1546 1559
46. D. Ribatti, and B. Nico A. Vacca The history of the angiogenic switch concept Leukemia 21 2007 44 52 (Pubitemid 44921833)
47. V.W. van Hinsbergh, M.A. Engelse, and P.H. Quax Pericellular proteases in angiogenesis and vasculogenesis Arterioscler. Thromb. Vasc. Biol. 26 2006 716 728 (Pubitemid 43732143)
48. M. Wang, and D. Zhao E.G. Lakatta Matrix metalloproteinase 2 activation of transforming growth factor-β1 (TGF-β1) and TGF-β1-type II receptor signaling within the aged arterial wall Arterioscler. Thromb. Vasc. Biol. 26 2006 1503 1509 (Pubitemid 44288975)
49. T. Eissing, and H. Conzelmann P. Scheurich Bistability analyses of a caspase activation model for receptor-induced apoptosis J. Biol. Chem. 279 2004 36892 36897 (Pubitemid 39129038)
50. J. Travis, and G.S. Salvesen Human plasma proteinase inhibitors Annu. Rev. Biochem. 52 1983 655 709 (Pubitemid 13030691)
51. M. Köhler, and S. Sen K. Hollemeyer Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction Thromb. Res. 62 1991 75 81
52. S. Legewie, N. Blüthgen, and H. Herzel Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability PLOS Comput. Biol. 2 2006 e120